FDA Investigator Maryna C Eichelberger, PhD
Maryna C Eichelberger, PhD has conducted inspections on 3 sites in 3 countries as of 05 Apr 2017. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
05 Apr 2017
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United Kingdom of Great Britain and Northern Ireland,
United States of America,
Australia
FDA Investigators that have inspected at least one site in common with Maryna C Eichelberger, PhD:
Anissa M Cheung,
Ann Marie Montemurro,
Arthur S Williams, Jr,
Brentley S Collins,
Burnell M Henry,
Carla J Lundi,
Christine A Harman, PhD,
Cynthia Jim, CSO,
Eileen A Liu,
Gene D Arcy,
Helen B Ricalde,
Jacqueline Mdiaz Albertini,
Jin Gao,
Lori A Carr,
Lori Peters,
Marlene L Davis,
Mihaly S Ligmond,
Omotunde O Osunsanmi,
Pankaj H Amin,
Prabhu P Raju,
Rose Ashley,
Simone E Pitts,
Steven A Rubin,
Susan M Jackson,
Thai D Truong,
Travis S Bradley
Maryna C Eichelberger, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2015 | FDA 483 | MEDIMMUNE U.K. LIMITED - Form 483, 2015-05-13 |
April, 2017 | FDA 483 | Protein Sciences Corporation - Form 483, 2017-04-13 |
March, 2011 | FDA 483 | Seqirus Pty Ltd - Form 483, 2011-03-31 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more